SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                  Schedule 13G

                    Under the Securities Exchange Act of 1934

                                 (Amendment No. )

                             Sangstat Medical Corp.
                                 (Name of Issuer)

                                     Common
                          (Title of Class of Securities)

                                   801003 10 4
                                 (CUSIP Number)

Check the following box if a fee is being paid with this statement [  ].  (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

                         (Continued on following page(s))



CUSIP No. 801003 10 4
Schedule 13G

1
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

  Dresdner Bank AG  13-2722082

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  [  ]                     (b)      [X]

3
SEC USE ONLY

4
CITIZENSHIP OR PLACE OF ORGANIZATION

  Frankfurt, Germany

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5 SOLE VOTING POWER             27,000
6 SHARED VOTING POWER           -0-
7 SOLE DISPOSITIVE POWER        27,000
8 SHARED DISPOSITIVE POWER      -0-

9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

  1,244,840

10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

  7.80%

12
TYPE OF REPORTING PERSON*

  BK, HC



Item 1(a) Name of Issuer:

  Sangstat Medical Corp.

Item 1(b) Address of Issuer's Principal Executive Offices:

  1505 Adams Drive
  Menlo Park, CA  94025

Item 2(a) Name of Person Filing:

  Dresdner Bank AG

Item 2(b) Address of Principal Business Office or, if none, Residence:

  Jurgen-Ponto-Platz 1
  60301 Frankfurt, Germany

Item 2(c) Citizenship:

  German Bank

Item 2(d) Title of Class of Securities:

  Common

Item 2(e) CUSIP Number:

  801003 10 4

Item 3.  If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
check whether the person filing is a:

  (g)  [X]  Parent Holding Company in accordance with Section 240.13d-
1(b)(ii)(G) under the Securities Exchange Act of 1934.  *See Exhibit A.

Item 4.  Ownership.

  See responses to Items 5, 6, 7, 8, 9, and 11 of Cover Page.

Item 5.  Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [  ].

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

  Not Applicable.

Item 7.  Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.

  See Exhibit A.

Item 8.  Identification and Classification of Members of the Group.

  Not Applicable.

Item 9. Notice of Dissolution of Group.

  Not Applicable.

Item 10.  Certification.

By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have the effect of changing
or influencing the control of the issuer of such securities and were not
acquired in connection with or as a participant in any transaction having such
purposes or effect.

Dr. Reinhard Pruesche

By /s/ William L. Price
   William L. Price
   Attorney-in-Fact

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Dresdner Bank AG

Dr. Reinhard Preusche                 January 30, 1998
  General Assistant Manager

By /s/ William L. Price
   William L. Price
   Attorney-in-Fact



EXHIBIT A

Dresdner Bank AG ("Dresdner") is an international banking organization
headquartered in Frankfurt, Germany. Dresdner RCM Global Investors LLC
("Dresdner RCM"), a wholly owned subsidiary of Dresdner, is an investment
adviser registered under Section 203 of the Investment Advisers Act of 1940.

Dresdner has filed this Schedule 13G pursuant to Rule 13d-1(b)(ii)(G) under the
Securities Exchange Act of 1934. Dresdner has beneficial ownership of the
securities reported on this Schedule 13G only to the extent that Dresdner may be
deemed to have beneficial ownership of securities deemed to be beneficially
owned by Dresdner RCM.

Dresdner is responsible for the timely filing of Schedule 13G and any amendments
thereto, and for the completeness and accuracy of the information concerning
Dresdner contained therein.


DRESDNER BANK AG

Dr. Reinhard Pruesche                 January 30, 1998

By /s/ William L. Price
   William L. Price
   Attorney-in-Fact